Coates, L., Landewé, R., McInnes, I., Mease, P., Ritchlin, C., Tanaka, Y., Asahina, A., Behrens, F., Gladman, D., Gossec, L., Orbai, A., Gottlieb, A., Warren, R., Ink, B., Bajracharya, R., Shende, V., Coarse, J. & Merola, J. 2024, 'Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL', RMD Open, 10(1), article no: e003855. https://doi.org/10.1136/rmdopen-2023-003855